-
1by Schmidt, Constanze Wiedmann, Felix Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in Naunyn-Schmiedeberg's archives of pharmacology (01.10.2012)“...Dronedarone is currently used for the treatment of paroxysmal and persistent atrial fibrillation (AF). Pharmacological inhibition of cardiac two-pore-domain...”
-
2by BIKOU, Olympia THOMAS, Dierk BAUER, Alexander TRAPPE, Kerstin LUGENBIEL, Patrick KELEMEN, Kamilla KOCH, Martin SOUCEK, Radim VOSS, Frederik BECKER, Rudiger KATUS, Hugo A Published in Cardiovascular research (2011)“...Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and effective treatment of AF still remains an unmet medical need. AF is associated...”
-
3by Gierten, Jakob Hassel, David Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in Biochimica et biophysica acta (01.01.2012)“...Two-pore-domain potassium (K(2P)) channels mediate K(+) background currents that stabilize the resting membrane potential and contribute to repolarization of...”
-
4by Rahm, Ann‐Kathrin Gierten, Jakob Kisselbach, Jana Staudacher, Ingo Staudacher, Kathrin Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in British journal of pharmacology (01.05.2012)“...BACKGROUND AND PURPOSE Two‐pore‐domain K+ channels (K2P) mediate K+ background currents that modulate the membrane potential of excitable cells. K2P18.1...”
-
5by LANG, SASKIA BECKER, RÜDIGER WILKE, STEFANIE HARTMANN, MECHTHILD HERZOG, WOLFGANG LÖWE, BERND Published in Pacing and clinical electrophysiology (01.01.2014)“...Objectives To determine (1) the frequency and course of anxiety disorders in patients with implantable cardioverter defibrillators (ICDs), (2) the predictors...”
-
7by Kristen, Arnt V., MD Dengler, Thomas J., MD Hegenbart, Ute, MD Schonland, Stefan O., MD Goldschmidt, Hartmut, MD Sack, Falk-Udo, MD Voss, Frederik, MD Becker, Rüdiger, MD Katus, Hugo A., MD Bauer, Alexander, MD Published in Heart rhythm (2008)“...Background Cardiac light-chain amyloidosis carries a high risk for death predominantly from progressive cardiomyopathy or sudden death (SCD). Independent risk...”
-
8by WOLLMANN, CHRISTIAN G LAWO, THOMAS KÜHLKAMP, VOLKER BECKER, RÜDIGER GARUTTI, CLAUDIO JACKSON, TROY BROWN, MARK L MAYR, HARALD Published in Pacing and clinical electrophysiology (01.09.2014)“...Background Implantable defibrillators (ICD) are highly effective in reducing arrhythmia‐related mortality. ICD shock therapy has been shown to increase...”
-
9by Aidery, Parwez Kisselbach, Jana Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in Biochimica et biophysica acta. Molecular basis of disease (01.04.2011)“...Hereditary long QT syndrome (LQTS) is associated with ventricular torsade de pointes tachyarrhythmias and sudden cardiac death. Mutations in a cardiac...”
-
10by Aidery, Parwez Kisselbach, Jana Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in Gene (10.12.2012)“...Long QT syndrome (LQTS) 1 is the most common type of inherited LQTS and is linked to mutations in the KCNQ1 gene. We identified a KCNQ1 missense mutation,...”
-
11by Gierten, Jakob Hassel, David Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in Biochimica et biophysica acta. Biomembranes (01.01.2012)“...Two-pore-domain potassium (K2P) channels mediate K+ background currents that stabilize the resting membrane potential and contribute to repolarization of...”
-
12by Soucek, Radim, MD Thomas, Dierk, MD Kelemen, Kamilla, MD Bikou, Olympia, MD Seyler, Claudia, PhD Voss, Frederik, MD Becker, Rüdiger, MD Koenen, Michael, PhD Katus, Hugo A., MD Bauer, Alexander, MD Published in Heart rhythm (2012)“...Background Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Gene therapy–dependent modulation of atrial electrophysiology may provide...”
-
13by Thomas, Dierk, MD Scholz, Eberhard P., MD Schweizer, Patrick A., MD Katus, Hugo A., MD Becker, Rüdiger, MD Published in Journal of electrocardiology (2012)“...Abstract Background and Purpose Remote robotic navigation (RRN) technology has been developed to facilitate catheter ablation of symptomatic atrial...”
-
14by Staudacher, Kathrin Baldea, Ioana Kisselbach, Jana Staudacher, Ingo Rahm, Ann‐Kathrin Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in The Journal of physiology (01.08.2011)“...Non‐technical summary The resting membrane potential of excitable cells such as neurones and cardiac myocytes depends on the distribution of potassium ions...”
-
15by Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in Drug design, development and therapy (06.01.2011)“...Atrial fibrillation (AF) is the most common sustained arrhythmia. Management of AF includes rate control, rhythm control if necessary, prevention of...”
-
17by Scholz, Eberhard Lugenbiel, Patrick Schweizer, Patrick A Xynogalos, Panagiotis Seyler, Claudia Zitron, Edgar Becker, Rüdiger Katus, Hugo A Thomas, Dierk Published in Journal of atrial fibrillation (01.02.2016)“...Cryoballoon (CB) ablation is successful in eliminating atrial fibrillation (AF). The purpose of this study was to assess procedural efficacy and safety of CB...”
-
19by Luciani, Etienne Nagy, Marliese Brachmann, Johannes Kuck, Karl-Heinz Andresen, Dietrich Willems, Stephan Hoffmann, Ellen Schumacher, Burghard Lewalter, Thorsten Spitzer, Stefan Tebbenjohanns, Jürgen Becker, Rüdiger Senges, Jochen Gonska, Bernd-Dieter Published in Journal of the American College of Cardiology (2011)
-
20by Staudacher, Ingo Jehle, Julian Staudacher, Kathrin Pledl, Hans-Werner Lemke, Dieter Schweizer, Patrick A Becker, Rüdiger Katus, Hugo A Thomas, Dierk“...Glioblastoma (GB) is associated with poor patient survival owing to uncontrolled tumor proliferation and resistance to apoptosis. Human ether-a-go-go-related...”
edited by Bishopric, Nanette H
Published in PloS one (2014-00-00)